Researchers at UT Health San Antonio may have found the first probiotic treatment for lupus, a chronic autoimmune disease that can cause debilitating symptoms.
Scientists have long known that the gut microbiome — the bacteria and microorganisms within the intestines — of patients with lupus differs from those without it, namely very low or nonexistent levels of certain bacteria. One of those is Faecalibacterium prausnitzii, which helps the body break down fiber.
Researchers at the Joe R. and Teresa Lozano Long School of Medicine had promising results when they gave that bacterium to mice that are prone to developing lupus, according to an April study published in the scientific journal Nature Communications.
The mice were fed the bacterium every few days before lupus symptoms developed. The researchers found that reintroducing the bacterium helped restore the balance between regulatory and inflammatory cells in the colon and lessened kidney damage caused by the disease.
“This is the first time in lupus research that we have identified a bacterium that is depleted and when returned, it helps,” said Laurence Morel, chair of the Long School of Medicine’s Microbiology, Immunology & Molecular Genetics department.
Lupus affects about 1.5 million Americans. There is no cure. Current treatments use immunosuppressants to manage symptoms, including joint pain, rashes, headaches, severe fatigue and organ inflammation, and prevent organ damage.
Immunosuppressants, however, can make patients prone to infection, such as bacterial sepsis or pneumonia, which is a major cause of lupus mortality.
The research team is now studying the effect of diet, the gut microbiome and the immune system to try to link different carbohydrates with health outcomes in lupus patients.